STEM CELLS A grant of 6 million euros for the HumEn project brings together leading European stem cell-research groups and industrial partners in a coordinated and collaborative effort aimed at developing glucose-responsive, insulin-producing beta cells for future cell-replacement therapy in diabetes. … Read the full press release
Ewell, Surrey, UK, 24-1-2014 — /EuropaWire/ — A new National Suicide Prevention Alliance (NSPA), aimed at reducing the number of suicides in England and improving support for those affected by suicide, has been launched. With members including Samaritans, Rethink Mental Illness and … Read the full press release
Oviedo, España, 24-1-2014 — /EuropaWire/ — Cajastur ha presentado hoy su colaboración con la Asociación Down Principado de Asturias (ASDA), asociación creada en 1985 y que se dedica a prestar apoyo a las personas con Síndrome de Down y sus familias. Al … Read the full press release
Posted in Financial, Healthcare, Non Profit, Spain
Tagged ASDA, Asociación Down Principado de Asturias, Cajastur, Carlos Siñeriz, colaboración, Inés Fernández, Síndrome de Down
General consensus that prohibitionist drugs policies have been largely unsuccessful Leaders debated the pace and direction of change in drugs policies The theme of the 44th World Economic Forum Annual Meeting is The Reshaping of the World: Consequences for Society, Politics and Business … Read the full press release
Posted in Healthcare, Law, Politics, Society, Switzerland
Tagged Aliko Dangote, Christophe de Margerie, Davos, Davos-Klosters, drugs policy, Enrique Acevedo, First Drugs Debate, Jiang Jianqing, Joseph Jimenez, Juan Manuel Santos, Judith Rodin, Kenneth Roth, Kofi Annan, Kofi Annan Foundation, Kris Gopalakrishnan, Marissa Mayer, Rick Perry, Switzerland, World Economic Forum
Stuttgart, Germany, 22-1-2014 — /EuropaWire/ — Following contract award at the beginning of January, the general contractor consortium consisting of Ed. Züblin AG and VAMED Germany have begun renovation works at the Charité university hospital in Berlin. Over the next three years, … Read the full press release
Posted in Business, Construction, Germany, Healthcare, Real Estate
Tagged Berlin, Charité university hospital, consortium, Ed. Züblin AG, renovate, VAMED Germany
Marks GSK’s fourth Breakthrough Therapy designation London, UK, 17-1-2014 — /EuropaWire/ — GlaxoSmithKline plc (LSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Tafinlar®(dabrafenib) for treatment of patients with metastatic BRAF V600E … Read the full press release
London, UK, 15-1-2014 — /EuropaWire/ — AstraZeneca and Bristol-Myers Squibb Company announced the US Food and Drug Administration (FDA) approved FARXIGA™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycaemic control in adults with … Read the full press release
The Commission infringed the procedural rules of the systems for authorising GMOs in the European Union Luxembourg, 16-12-2013 — /EuropaWire/ — In the territory of the European Union, genetically modified organisms (GMOs) may be released into the environment or placed on the market only … Read the full press release
Posted in Agriculture, European Union, Germany, Government, Healthcare, Hungary, Law, Luxembourg, Pharma & Biotech, Science
Tagged animal feed, Animal Health, authorising GMOs, BASF Plant Science GmbH, EU General Court, European Food Safety Authority, genetically modified food, genetically modified food feed, genetically modified organisms, genetically modified potato Amflora, GMOs, human health, Hungary v Commission case, Judgment, potato Amflora, procedural rules
Novartis supplies MenB vaccine for a vaccination program at Princeton, following approvals by health authorities and University officials Bexsero, already licensed in Europe, Australia and Canada, is the only broad coverage vaccine to help protect against MenB disease MenB is … Read the full press release
In two Phase III studies, Jakavi ® reduced the risk of death and maintained spleen reductions at three years compared to conventional therapy and placebo Similar survival benefit seen in patients with and without high-risk mutations Separate analysis shows Jakavi may increase … Read the full press release
ENESTnd data indicate trend for longer overall survival and event-free survival in newly diagnosed Ph+ CML patients on Tasigna versus Glivec[1] Data demonstrated higher rates of early and deeper molecular response in newly diagnosed patients, including MR4.5, and a reduced … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland
Tagged Giuseppe Saglio, Glivec®, imatinib, leukemia, nilotinib, Novartis, Novartis's Tasigna®, Ph+ CML, Phase III studies
For media outside of the US, the UK & Canada only The efficacy and safety profile of Pradaxa® (dabigatran etexilate) was maintained regardless of patient characteristics1,2,3,4 Pooled safety data favour Pradaxa® treatment over warfarin and provide further reassurance1-4 The analysed … Read the full press release
“Industry on Campus” as part of the Excellence Initiative – application-oriented research for better vision Tübingen, Germany, 12-12-2013 — /EuropaWire/ — More than four billion people all over the world are reliant on ophthalmic or medical devices to enable them to optimally … Read the full press release
Düsseldorf, Deutschland, 11-12-2013 — /EuropaWire/ — Eine Charity-Veranstaltung in besonderer Atmosphäre. Bereits zum fünften Mal unterstützte Henkel / Schwarzkopf den DKMS LIFE Charity Ladies` Lunch, zu dem sich am 2. Dezember rund 90 engagierte und prominente Frauen in einer ganz besonderen … Read the full press release
Experts present lessons learned from past control programs and new approaches to eliminating diseases such as leprosy and malaria. The Novartis Foundation for Sustainable Development (NFSD) launches a new strategy to help eliminate leprosy. For over 15 years, the annual symposium of … Read the full press release
Basel, Switzerland, 11-12-2013 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive aspergillosis. QIDP status provides priority review and … Read the full press release
Posted in Government, Healthcare, Pharma & Biotech, Switzerland
Tagged Barbara Zink, Basilea Pharmaceutica, fungal infections, invasive aspergillosis, Isavuconazole, isavuconazonium sulfate, Peer Nils Schröder, QIDP, Qualified Infectious Disease Product, Ronald Scott, treatment, U.S. FDA, zygomycosis
A group of medical students at the University of Aberdeen have formed what is believed to be Europe’s first undergraduate medical society for the promotion of geriatric medicine and quality care for older people. Aberdeen, Scotland, United Kingdom, 10-12-2013 — /EuropaWire/ … Read the full press release
Newcastle, UK, 10-12-2013 — /EuropaWire/ — A study by Newcastle University researchers into the effects of sugars on our oral health recommends cutting down on the sweet additive as part of a global initiative to reduce tooth decay. Since 1990 the World … Read the full press release
Posted in Education, Healthcare, Science, United Kingdom
Tagged cutting down on sweet additive, dental caries, dental cavities, free sugars, Journal of Dental Research, Newcastle University, Nutrition, oral health, Professor Paula Moynihan, reduce tooth decay, study, sugars, sweet additive, tooth decay
Leeds, UK, 07-12-2013 — /EuropaWire/ — Researchers have identified a resistance protein that allows bacteria to survive chlorhexidine, an antiseptic commonly used in wipes, cleansers and mouthwashes in hospitals. A study led jointly by the University of Leeds and Macquarie University … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged Acinetobacter baumannii, bacteria, chlorhexidine, cleansers, hospitals, Leeds University, Macquarie University, mouthwashes, Professor Ian Paulsen, Professor Peter Henderson, resistance protein, Sally Davies, study, wipes
People who work in shifts for long periods run health risks. The probable cause is a disruption of their circadian rhythm, which is controlled by the biological clock (a group of cells located in the brain). Chronobiologist Maan van de … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?